AN OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP, PROSPECTIVE CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF AGOMELATINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER